Decipher is the first genomic test for postoperative prostate cancer to gain Medicare coverage, adding unique information to guide patient care after radical prostatectomy.
Read More
Australian researchers have formed an international team to help quickly determine life-threatening cases of prostate cancer compared with cancer that may not require treatment.
Read MoreAn MD Anderson study identifies a genetic variant near the KLK3 gene that could stratify GS7 prostate cancer patients.
Read MoreA preliminary study suggests that metastatic prostate cancer patients with detectable levels of AR-V7 in their blood should avoid two widely used drugs.
Read More
An international multispecialty team offers guidance on eligibility for active surveillance, providing low-risk prostate cancer patients a less-harmful treatment option.
Read More